Use of molnupiravir: A Danish nationwide drug utilization study.

Louise Ladebo Rasmussen Lotte Rasmussen Peter Bjødstrup JensenMette LindahlAnne Lindebo Holm Øvrehus Jesper Hallas Mette Reilev

Published in: Pharmacoepidemiology and drug safety (2023)

Molnupiravir was mainly prescribed by general practitioners to RT-PCR SARS-CoV-2 positive individuals who had a potentially increased risk of severe COVID-19. Though some off-label prescribing occurred, our study indicates a high level of adherence to contemporary guidelines.

Keyphrases

sars cov
primary care
early onset
adipose tissue
real time pcr